Garfinkel: Many Healthcare Startup Exits Occur Between $200M and $400M
Jan Garfinkel · Jan Garfinkle – Arboretum Ventures (Manager Meetings, EP.09) · Sep 2, 2021 · at 33:06
Jan Garfinkel of Arboretum Ventures explains the math behind healthcare venture capital exits and capital efficiency.
0:00 / 0:06exact quote · 7.0s
720p mp4 · rendered on demand · StarZero watermark
“In the world we live in, in healthcare, many of the exits are in the 200 to four hundred million dollar range.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Jan Garfinkel
Garfinkel: Midwest Startups Cost 33% Less to Build, Adding 1x Return
“The beauty of being in the Midwest and focusing primarily on Midwestern companies is that it takes about a third less dollars to develop the company in the Midwest because salaries, rent, vendor costs, just all those things all combined. You basically get an a…”
Garfinkel: Pharma Adjacencies Capture Upside Without Binary Trial Failure Risk
“Pharma adjacencies, which is companies that play in the pharma space, but it's without a drug, so they have the same upside potential, because pharma has big upside potential, but without the binary risk that the drug would fail in phase three.”
Garfinkel: Venture Capital Skills Can Be Taught; Cultural Fit Cannot
“We feel we can teach anybody how to do venture, how we evaluate companies, how we help the board level. We can teach all of those things. We want to make sure they're a cultural fit from a personality standpoint and a work ethic.”
Garfinkel: Half of Arboretum's 15 Major Exits Were Within One Mile
“I think we've invested now in 50 or 55 companies. We've had about 20 exits, but 15 that were in sort of the five to 10 X range, and when you look at that, half of them are a mile from our office.”